Please use this identifier to cite or link to this item:
https://hdl.handle.net/11000/39485
Antiviral treatment or mAbs for persistent SARS‐COV‐2 infection in patients with hematologic malignancies: A case series.
View/Open: Antiviral treatment or mAbs for persistent SARS‐COV‐2 infection in patients with hematologic malignancies. A case series.pdf
496,82 kB
Adobe PDF
Share:
This resource is restricted
Title:
Antiviral treatment or mAbs for persistent SARS‐COV‐2 infection in patients with hematologic malignancies: A case series. |
Authors:
Pérez Catalán, Ignacio 
Gómez‐Alfaro, Iris
García‐Muñoz, Sergio
ROIG MARTI, CELIA
Rodríguez, Noelia Lozano
Fabra Juana, Sergio
Esteve Gimeno, Maria José
Gascón‐Buj, Adriana
Freiría Alberte, Carmen
Clavel‐Pia, Juana
Torres García, Miguel
REIG-VALERO, ROBERTO
Ferrando‐Piqueres, Raúl
MATEU-CAMPOS, MARIA-LIDON
Usó Blasco, Jorge
Ramos Rincón, José Manuel |
Editor:
Wiley |
Department:
Departamentos de la UMH::Medicina Clínica |
Issue Date:
2023 |
URI:
https://hdl.handle.net/11000/39485 |
Keywords/Subjects:
antiviral treatment
mAbs
SARS-COV-2 infection |
Knowledge area:
CDU: Ciencias aplicadas: Medicina |
Type of document:
info:eu-repo/semantics/article |
Access rights:
info:eu-repo/semantics/closedAccess |
DOI:
https://doi.org/10.1002/jmv.28865 |
Published in:
Journal of Medical Virology, Vol. 95, Issue 6 (2023) |
Appears in Collections:
Artículos Medicina Clínica
|
???jsp.display-item.text9???
.png){kind=logo}